Exelixis, Inc. Profile Avatar - Palmy Investing

Exelixis, Inc.

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
Strategy & Leadership

Executives & BofD Beta

Total Compensation ($)

Scope

Executives

Yet No Data For Executives

Directors

Yet No Data For Directors

C-Suite and VPs/SVPs

Yet No Data For Executives

Board of Directors (BofD)

Yet No Data For Directors

End of EXEL's Analysis
CIK: 939767 CUSIP: 30161Q104 ISIN: US30161Q1040 LEI: - UEI: -
Secondary Listings
EXEL has no secondary listings inside our databases.